Analyst Ratings for Dermata Therapeutics In (DRMA)
DRMA Rating Summary
DRMA Price Target Summary
- Highest: $40.00 (RBC Capital)
- Lowest: $10.00 (Maxim Group)
- Average: $25.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$25.00 (+2036.8%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$25.00 (+2036.8%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/23/2026 | RBC Capital | Brian Abrahams | New Coverage | Outperform (N/A) |
40.00 (N/A) |
1.30 (1.17) |
-10% | Details |
| 9/21/2021 | Brookline Capital Markets | Kumaraguru Raja | New Coverage | Buy (N/A) |
14.00 (N/A) |
4.87 (1.17) |
-75.98% | Details |
 |
||||||||
